We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Mirum Pharmaceuticals
MIRM
$6.89B
| $399K | ﹤0.01% |
10,230
+4,006
| +64% | +$160K |
|
1277
Arvinas
ARVN
$518M
| $399K | ﹤0.01% |
16,196
+5,216
| +48% | +$136K |
|
1278
Ardelyx
ARDX
$1.24B
| $398K | ﹤0.01% |
57,826
+12,501
| +28% | +$73.8K |
|
1279
TD Synnex
SNX
$19.4B
| $398K | ﹤0.01% |
3,315
-349
| -10% | -$40.4K |
|
|
EQC
1280
DELISTED
Equity Commonwealth
EQC
| $398K | ﹤0.01% |
19,987
+6,304
| +46% | +$126K |
|
1281
EastGroup Properties
EGP
$11.5B
| $396K | ﹤0.01% |
2,121
-146
| -6% | -$26.9K |
|
1282
Syndax Pharmaceuticals
SNDX
$1.84B
| $396K | ﹤0.01% |
20,556
-11,044
| -35% | -$228K |
|
1283
Extreme Networks
EXTR
$3.86B
| $395K | ﹤0.01% |
26,302
+6,796
| +35% | +$96.3K |
|
1284
Vertex
VERX
$1.92B
| $395K | ﹤0.01% |
+10,255
| New | +$378K |
|
1285
Carlyle Group
CG
$16.3B
| $395K | ﹤0.01% |
9,166
-1,017
| -10% | -$42.7K |
|
1286
International Seaways
INSW
$4.57B
| $394K | ﹤0.01% |
7,634
+2,190
| +40% | +$115K |
|
1287
Leonardo DRS
DRS
$12.8B
| $393K | ﹤0.01% |
13,911
+4,707
| +51% | +$129K |
|
1288
NeoGenomics
NEO
$1.81B
| $393K | ﹤0.01% |
26,614
+6,995
| +36% | +$109K |
|
1289
Hillman Solutions
HLMN
$1.56B
| $392K | ﹤0.01% |
37,138
+10,968
| +42% | +$106K |
|
1290
Primerica
PRI
$9.81B
| $391K | ﹤0.01% |
1,475
-147
| -9% | -$37.1K |
|
|
B
1291
DELISTED
Barnes Group Inc.
B
| $391K | ﹤0.01% |
9,675
+2,097
| +28% | +$82.6K |
|
|
DVAX
1292
DELISTED
Dynavax Technologies
DVAX
| $390K | ﹤0.01% |
35,034
+6,979
| +25% | +$76.9K |
|
1293
Ingredion
INGR
$6.38B
| $390K | ﹤0.01% |
2,837
-259
| -8% | -$32.9K |
|
1294
BioCryst Pharmaceuticals
BCRX
$2.37B
| $390K | ﹤0.01% |
51,272
+13,144
| +34% | +$99.9K |
|
1295
AvePoint
AVPT
$2.6B
| $390K | ﹤0.01% |
33,102
+1,286
| +4% | +$14.1K |
|
1296
Privia Health
PRVA
$3.21B
| $388K | ﹤0.01% |
21,295
+4,136
| +24% | +$78.9K |
|
1297
GameStop
GME
$9.5B
| $388K | ﹤0.01% |
16,908
+4,201
| +33% | +$96.1K |
|
1298
Graphic Packaging
GPK
$3.26B
| $387K | ﹤0.01% |
13,083
-1,408
| -10% | -$40.1K |
|
1299
H&R Block
HRB
$5.18B
| $387K | ﹤0.01% |
6,085
-496
| -8% | -$29.6K |
|
|
SKX
1300
DELISTED
Skechers
SKX
| $387K | ﹤0.01% |
5,778
-466
| -7% | -$30.6K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.